Off-label ketamine still a worry

Increasing numbers of doctors are offering ketamine as an off-label treatment for psychiatric disorders, say researchers, raising further concerns about the practice.

While there is broad agreement that ketamine-like drugs hold considerable promise as a novel antidepressant, two US psychiatrists warn that prescribing it off-label is premature.